Patient Guide: A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular Lymphoma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 112 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04712097
Status: ACTIVE_NOT_RECRUITING
Condition: Lymphoma, Lymphoma, Follicular
Phase: PHASE3

Where You Can Participate

This study is available at 112 locations across the country.

Top locations include:
  • • Duarte, California
  • • Atlanta, Georgia
  • • Fort Wayne, Indiana
  • • And 109 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular Lymphoma - Join Clinical Trial NCTNCT04712097

How to Join This Clinical Trial - NCTNCT04712097

Learn how to participate in this PHASE3 trial studying an investigational therapy for Lymphoma, Lymphoma, Follicular. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Lymphoma, Lymphoma, Follicular. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Lymphoma, Lymphoma, Follicular
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04712097 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 112 locations. Find a study site near you:

Clinical Research Site

Duarte, California 91010 - United States

Status: Contact for availability

Clinical Research Site

Atlanta, Georgia 30322 - United States

Status: Contact for availability

Clinical Research Site

Fort Wayne, Indiana 46804 - United States

Status: Contact for availability

Clinical Research Site

Noblesville, Indiana 46062 - United States

Status: Contact for availability

Clinical Research Site

Baltimore, Maryland 21231 - United States

Status: Contact for availability

Clinical Research Site

Ann Arbor, Michigan 48109 - United States

Status: Contact for availability

Clinical Research Site

Grand Rapids, Michigan 49503 - United States

Status: Contact for availability

Clinical Research Site

Saint Louis, Missouri 63110 - United States

Status: Contact for availability

Clinical Research Site

Bronx, New York 10461 - United States

Status: Contact for availability

Clinical Research Site

Bronx, New York 10467 - United States

Status: Contact for availability

And 102 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Lymphoma, Lymphoma, Follicular:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships